Corbus Pharmaceuticals Holdings, Inc.CRBPNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank85
3Y CAGR+63.2%
5Y CAGR-6.5%
Year-over-Year Change
Research and development spending
3Y CAGR
+63.2%/yr
vs -24.1%/yr prior
5Y CAGR
-6.5%/yr
Recent acceleration
Acceleration
+87.3pp
Accelerating
Percentile
P85
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $70.09M | +117.5% |
| 2024 | $32.22M | +3.4% |
| 2023 | $31.17M | +93.1% |
| 2022 | $16.14M | -55.7% |
| 2021 | $36.45M | -62.9% |
| 2020 | $98.27M | +9.7% |
| 2019 | $89.60M | +84.3% |
| 2018 | $48.61M | +86.7% |
| 2017 | $26.04M | +68.7% |
| 2016 | $15.44M | - |